Association Between Neutrophil-Lymphocyte Ratio and 30-Day Infection and Thrombotic Outcomes After Intraventricular Hemorrhage : A CLEAR III Analysis

© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society..

BACKGROUND: Serum neutrophil-lymphocyte ratio (NLR) is a surrogate marker for the inflammatory response after intracerebral hemorrhage (ICH) and is associated with perihematomal edema and long-term functional outcomes. Whether NLR is associated with short-term ICH complications is poorly understood. We hypothesized that NLR is associated with 30-day infection and thrombotic events after ICH.

METHODS: We performed a post hoc exploratory analysis of the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III trial. The study exposure was the serum NLR obtained at baseline and on days 3 and 5. The coprimary outcomes, ascertained at 30 days, were any infection and a thrombotic event, defined as composite of cerebral infarction, myocardial infarction, or venous thromboembolism; both infection and thrombotic event were determined through adjudicated adverse event reporting. Binary logistic regression was used to study the relationship between NLR and outcomes, after adjustment for demographics, ICH severity and location, and treatment randomization.

RESULTS: Among the 500 patients enrolled in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III trial, we included 303 (60.6%) without missing data on differential white blood cell counts at baseline. There were no differences in demographics, comorbidities, or ICH severity between patients with and without data on NLR. In adjusted logistic regression models, NLR ascertained at baseline (odds ratio [OR] 1.03; 95% confidence interval [CI] 1.01-1.07, p = 0.03) and NLR ascertained at day 3 were associated with infection (OR 1.15; 95% CI 1.05-1.20, p = 0.001) but not with thrombotic events. Conversely, NLR at day 5 was associated with thrombotic events (OR 1.07, 95% CI 1.01-1.13, p = 0.03) but not with infection (OR 1.13; 95% CI 0.76-1.70, p = 0.56). NLR at baseline was not associated with either outcome.

CONCLUSIONS: Serum NLR ascertained at baseline and on day 3 after randomization was associated with 30-day infection, whereas NLR obtained on day 5 was associated with thrombotic events after ICH, suggesting that NLR could be a potential early biomarker for ICH-related complications.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Neurocritical care - 40(2024), 2 vom: 19. März, Seite 529-537

Sprache:

Englisch

Beteiligte Personen:

Kaleem, Safa [VerfasserIn]
Zhang, Cenai [VerfasserIn]
Gusdon, Aaron M [VerfasserIn]
Oh, Stephanie [VerfasserIn]
Merkler, Alexander E [VerfasserIn]
Avadhani, Radhika [VerfasserIn]
Awad, Isaam [VerfasserIn]
Hanley, Daniel F [VerfasserIn]
Kamel, Hooman [VerfasserIn]
Ziai, Wendy C [VerfasserIn]
Murthy, Santosh B [VerfasserIn]

Links:

Volltext

Themen:

Biomarkers
Hematoma expansion
Intracerebral hemorrhage
Intraventricular hemorrhage
Intraventricular hemorrhage expansion
Journal Article
Outcome

Anmerkungen:

Date Completed 25.03.2024

Date Revised 25.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s12028-023-01774-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358509874